
Syndax Pharmaceuticals Hits Day Low at $13.03 Amid Price Pressure
2025-10-27 17:39:19Syndax Pharmaceuticals, Inc. faced a notable decline in stock performance, reflecting ongoing challenges and negative results over 11 consecutive quarters. The company's one-year performance shows a significant drop, contrasting with broader market gains. Despite slight promoter confidence, Syndax's market position remains precarious within the pharmaceuticals sector.
Read full news article
Syndax Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Dynamics
2025-10-27 15:44:23Syndax Pharmaceuticals, Inc. has experienced significant stock fluctuations, currently priced at $13.53, down from a 52-week high of $22.50. The company has underperformed compared to the S&P 500 over the past year and three years, indicating ongoing challenges in the biotechnology sector.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






